Vaginal Progesterone for Treatment of Threatened Miscarriage

Summary

The purpose of the study is to assess the efficacy of vaginal micronized progesterone in the treatment of threatened miscarriage. All eligible pregnant women will be randomized to either receive vaginal progesterone or no treatment.Evaluation will be two weeks after intervention, then every 4 weeks up to 28 weeks gestation or termination of pregnancy.

Timeline

Start

2016-02

Primary completion

2017-02

Completion

2018-02

Drugs

Indications

No indication recorded.